Nutraceuticals: 

Sea Moss

Patients often inquire about Sea Moss and whether it is recommended for use. In an effort to field these questions, information provided by a reputable AI search is presented here. This is not meant to be an exhaustive review, but rather a simple resource for those looking for guidance only.

See: 

 

Key to Links:

  • Grey text – handout
  • Red text – another page on this website
  • Blue text – Journal publication

Definitions and Terms Related to Pain

 

Sea Moss

Sea moss (commonly referring to red seaweeds such as Chondrus crispus and Gracilaria spp.) is recognized as a nutraceutical supplement due to its high content of minerals (notably iodine), vitamins, polysaccharides, and bioactive compounds with antioxidant, anti-inflammatory, antimicrobial, and antidiabetic properties. However, robust clinical efficacy data in humans are limited, and most evidence is preclinical or based on traditional use and compositional analysis.

Multiple reviews highlight that seaweeds, including sea moss, are nutrient-dense and contain compounds with potential health benefits such as improved immune function, metabolic health, and chronic disease prevention.[1][2][3][4][5][6][7] Specific activities attributed to sea moss and other seaweeds include antioxidant, anti-inflammatory, antidiabetic, and antimicrobial effects, largely supported by in vitro and animal studies rather than large human trials.[1][2][3][4][5][6][7] A recent meta-analysis found that seaweed supplementation (including brown and red algae) can improve postprandial blood glucose and HbA1c, with higher doses (≥1000 mg/day) showing greater benefit, though most studies did not focus specifically on sea moss.[8]

Recommended Doses

Typical recommended doses for sea moss supplementation are not standardized in the medical literature. Commercial products often suggest 1–4 grams of dried sea moss per day, which aligns with safety data for iodine intake: 4 grams/day of dehydrated Irish moss (Chondrus crispus) provides about 25% of the recommended daily iodine intake for children and is considered safe for adults, but excessive intake (e.g., >286 g/day) risks exceeding the upper limit for iodine and may cause thyroid dysfunction.[9][10] The mineral content, especially iodine, varies widely by species and source, so dosing should be approached cautiously, especially in populations at risk for thyroid disease.[9][11][10]

In Summary:

  • Sea moss is a promising nutraceutical due to its nutrient and bioactive profile, with potential benefits for metabolic, immune, and chronic disease health, but human clinical efficacy data are limited.
  • Typical supplementation is 1–4 g dried sea moss daily; higher doses risk excessive iodine intake.
  • More rigorous human trials are needed to establish efficacy, optimal dosing, and long-term safety.[12][5][9][10]

Caution: Monitor for iodine excess and potential heavy metal contamination, as seaweeds can accumulate toxic elements.[12][13][11][10]

References

  1. Phytochemical and Potential Properties of Seaweeds and Their Recent Applications: A Review. El-Beltagi HS, Mohamed AA, Mohamed HI, et al. Marine Drugs. 2022;20(6):342. doi:10.3390/md20060342.
  2. Bioactive Compounds of Marine Algae and Their Potential Health and Nutraceutical Applications: A Review. Cadar E, Popescu A, Dragan AM, et al. Marine Drugs. 2025;23(4):152. doi:10.3390/md23040152.
  3. Nutraceutical Potential of Seaweed Polysaccharides: Structure, Bioactivity, Safety, and Toxicity. Tanna B, Mishra A. Comprehensive Reviews in Food Science and Food Safety. 2019;18(3):817-831. doi:10.1111/1541-4337.12441.
  4. Nutraceutical Benefits of Seaweeds and Their Phytocompounds: A Functional Approach to Disease Prevention and Management. Kahwa I, Omara T, Ayesiga I, et al. Journal of the Science of Food and Agriculture. 2025;. doi:10.1002/jsfa.14287.
  5. Rehashing Our Insight of Seaweeds as a Potential Source of Foods, Nutraceuticals, and Pharmaceuticals. Baghel RS, Choudhary B, Pandey S, et al. Foods (Basel, Switzerland). 2023;12(19):3642. doi:10.3390/foods12193642.
  6. Seaweed in the Diet as a Source of Bioactive Metabolites and a Potential Natural Immunity Booster: A Comprehensive Review. Mandal AK, Parida S, Behera AK, et al. Pharmaceuticals (Basel, Switzerland). 2025;18(3):367. doi:10.3390/ph18030367.
  7. Seaweeds as a Functional Ingredient for a Healthy Diet. Peñalver R, Lorenzo JM, Ros G, et al. Marine Drugs. 2020;18(6):E301. doi:10.3390/md18060301.
  8. Brown Seaweed Consumption as a Promising Strategy for Blood Glucose Management: A Comprehensive Meta-Analysis. Kim YR, Park MJ, Park SY, Kim JY. Nutrients. 2023;15(23):4987. doi:10.3390/nu15234987.
  9. Risk Assessment of Iodine Intake From the Consumption of Red Seaweeds (Palmaria Palmata and Chondrus Crispus). Darias-Rosales J, Rubio C, Gutiérrez ÁJ, Paz S, Hardisson A. Environmental Science and Pollution Research International. 2020;27(36):45737-45741. doi:10.1007/s11356-020-10478-9.
  10. Iodine Content in Bulk Biomass of Wild-Harvested and Cultivated Edible Seaweeds: Inherent Variations Determine Species-Specific Daily Allowable Consumption. Roleda MY, Skjermo J, Marfaing H, et al. Food Chemistry. 2018;254:333-339. doi:10.1016/j.foodchem.2018.02.024.
  11. Minerals From Macroalgae Origin: Health Benefits and Risks for Consumers. Circuncisão AR, Catarino MD, Cardoso SM, Silva AMS. Marine Drugs. 2018;16(11):E400. doi:10.3390/md16110400.
  12. Risks and Benefits of Consuming Edible Seaweeds. Cherry P, O’Hara C, Magee PJ, McSorley EM, Allsopp PJ. Nutrition Reviews. 2019;77(5):307-329. doi:10.1093/nutrit/nuy066.
  13. Minerals in Edible Seaweed: Health Benefits and Food Safety Issues. Lozano Muñoz I, Díaz NF. Critical Reviews in Food Science and Nutrition. 2022;62(6):1592-1607. doi:10.1080/10408398.2020.1844637.

Human Clinical Trials

Human clinical trials specifically investigating sea moss (Chondrus crispus, Gracilaria spp.) supplementation as a nutraceutical are extremely limited; most available clinical data focus on other seaweed species or on extracted polysaccharides, rather than whole sea moss. The majority of evidence for sea moss comes from compositional analysis, preclinical studies, and traditional use, with only a few human studies on related seaweed polysaccharides.

A recent review of the literature confirms that while seaweeds—including sea moss—are widely recognized for their nutritional and bioactive properties, there is a lack of robust human intervention studies directly assessing clinical efficacy and safety for sea moss itself.[1][2][3][4][5] Most clinical trials have focused on brown seaweeds (e.g., Ascophyllum nodosum, Fucus vesiculosus) or on purified polysaccharides from green algae (e.g., Ulva sp.), rather than red seaweeds like sea moss.[6][7][8]

Design and outcomes of relevant human studies:

  • The most directly relevant clinical studies have used oral supplementation of algal sulfated polysaccharides (not specifically sea moss) in overweight adults, with doses of 2–4 g/day for 6–12 weeks. These randomized, double-blind, placebo-controlled trials reported improvements in plasma lipids, reductions in inflammatory markers (CRP, cytokines), and favorable shifts in gut microbiota, but did not assess sea moss specifically.[8]
  • Trials of brown seaweed supplementation (5 g/day for 5 weeks) in patients with type 2 diabetes found no significant effect on average blood glucose levels, and safety was acceptable with no serious adverse events.[7]
  • Reviews consistently note that safety concerns for seaweed supplements center on iodine excess and potential heavy metal contamination, but clinical trials using moderate doses (1–4 g/day) have not reported significant adverse effects.[1][2][3]

Summary:

  • No large, high-quality human clinical trials have directly evaluated sea moss supplementation for clinical endpoints.
  • Most human data are extrapolated from studies of other seaweeds or their polysaccharides, which show potential benefits for metabolic and inflammatory markers at doses of 2–5 g/day, with good short-term safety.
  • Further research is needed to establish the clinical efficacy, optimal dosing, and long-term safety of sea moss as a nutraceutical supplement in humans.[1][2][3][4][5]

References

  1. Risks and Benefits of Consuming Edible Seaweeds. Cherry P, O’Hara C, Magee PJ, McSorley EM, Allsopp PJ. Nutrition Reviews. 2019;77(5):307-329. doi:10.1093/nutrit/nuy066.
  2. Rehashing Our Insight of Seaweeds as a Potential Source of Foods, Nutraceuticals, and Pharmaceuticals. Baghel RS, Choudhary B, Pandey S, et al. Foods (Basel, Switzerland). 2023;12(19):3642. doi:10.3390/foods12193642.
  3. Phytochemical and Potential Properties of Seaweeds and Their Recent Applications: A Review. El-Beltagi HS, Mohamed AA, Mohamed HI, et al. Marine Drugs. 2022;20(6):342. doi:10.3390/md20060342.
  4. Bioactive Compounds of Marine Algae and Their Potential Health and Nutraceutical Applications: A Review. Cadar E, Popescu A, Dragan AM, et al. Marine Drugs. 2025;23(4):152. doi:10.3390/md23040152.
  5. Nutraceutical Benefits of Seaweeds and Their Phytocompounds: A Functional Approach to Disease Prevention and Management. Kahwa I, Omara T, Ayesiga I, et al. Journal of the Science of Food and Agriculture. 2025;. doi:10.1002/jsfa.14287.
  6. Clinical Efficacy of Brown Seaweeds Ascophyllum Nodosum and Fucus Vesiculosus in the Prevention or Delay Progression of the Metabolic Syndrome: A Review of Clinical Trials. Keleszade E, Patterson M, Trangmar S, Guinan KJ, Costabile A. Molecules (Basel, Switzerland). 2021;26(3):714. doi:10.3390/molecules26030714.
  7. The Effect of Sargassum Fusiforme and Fucus Vesiculosus on Continuous Glucose Levels in Overweight Patients With Type 2 Diabetes Mellitus: A Feasibility Randomized, Double-Blind, Placebo-Controlled Trial. Geurts KAM, Meijer S, Roeters van Lennep JE, et al. Nutrients. 2024;16(12):1837. doi:10.3390/nu16121837.
  8. Improved Plasma Lipids, Anti-Inflammatory Activity, and Microbiome Shifts in Overweight Participants: Two Clinical Studies on Oral Supplementation With Algal Sulfated Polysaccharide. Roach LA, Meyer BJ, Fitton JH, Winberg P. Marine Drugs. 2022;20(8):500. doi:10.3390/md20080500.

Emphasis on Education

 

Accurate Clinic promotes patient education as the foundation of it’s medical care. In Dr. Ehlenberger’s integrative approach to patient care, including conventional and complementary and alternative medical (CAM) treatments, he may encourage or provide advice about the use of supplements. However, the specifics of choice of supplement, dosing and duration of treatment should be individualized through discussion with Dr. Ehlenberger. The following information and reference articles are presented to provide the reader with some of the latest research to facilitate evidence-based, informed decisions regarding the use of conventional as well as CAM treatments.

 

For medical-legal reasons, access to these links is limited to patients enrolled in an Accurate Clinic medical program.

 

Should you wish more information regarding any of the subjects listed – or not listed –  here, please contact Dr. Ehlenberger. He has literally thousands of published articles to share on hundreds of topics associated with pain management, weight loss, nutrition, addiction recovery and emergency medicine. It would take years for you to read them, as it did him.

 

For more information, please contact Accurate Clinic.

 

Supplements recommended by Dr. Ehlenberger may be purchased commercially online

Please read about our statement regarding the sale of products recommended by Dr. Ehlenberger.

 

 

.